Wednesday, 01 December 2021
- Welcome Guest
- Digital Edition
- Subscribe
- Newsletter
- Media Kit
- Login/Sign Up
World | 15 October 2021 | News
TB deaths increase first time in over a decade: WHO 2021 report
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in...Read more
Malaysia | 01 October 2021 | Opinion
Therapeutic approaches for the treatment of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death globally. In Malaysia, HCC is the ...Read more
China | 23 November 2021 | News
China to develop Next-Gen COVID-19 oral antiviral treatments
Simcere Pharmaceutical Group has reached collaboration agreement with the Shanghai Institute of Materia M...Read more
Japan | 02 November 2021 | News
Japan offers new treatment option for brain cancer
Japanese firm Daiichi Sankyo Company has launched DELYTACT® (teserpaturev/G47∆), an oncolytic virus develo...Read more
Singapore | 02 November 2021 | News
Singapore assembles world’s largest and highest-resolution atlas of gastric cancer
Scientists in Singapore have assembled the world’s largest and highest-resolution atlas of gastric cance...Read more
China | 02 November 2021 | News
US-China ink gene therapy research agreement for Duchenne Muscular Dystrophy
CANbridge Pharmaceuticals, Inc., a leading China-based global rare disease-focused biopharmaceutical company h...Read more
New Zealand | 26 October 2021 | News
NZ invests $8.1M in MedTech to translate science into real life
The New Zealand (NZ) government is investing $8.1 million over three years in the MedTech Research Translator,...Read more
Korea | 25 October 2021 | News
Korea offers smarter medical treatment with novel sensor technology
Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have designed a thin polyme...Read more
World | 29 October 2021 | News
MilliporeSigma advances next generation antibody-drug conjugate therapies
MilliporeSigma, the U.S. and Canadian Life Science business of Merck KGaA, Darmstadt, Germany, a leading ...Read more
North America | 21 October 2021 | News
Waters, University of Delaware announce bioprocessing innovation partnership
Waters Corporation and the University of Delaware, US have announced a five-year research partnership to devel...Read more
Focusing on
VIGILANCE & PREPAREDNESS
Despite advances in development of countermeasures such as diagnostics, therapeutics and vaccines, world travel and increased global interdependence have added layers of complexity to containing infectious diseases. COVID-19, an outcome of weaponisation by genetic manipulation as part of ‘gain of function’ research, had brought the entire world to its knees in less than six months.
Now, researchers and policymakers are being more vigilant towards surveillance and management of emerging infectious disease threats, and revisit global mechanisms for the control of pandemic disease. In addition to other countries across the globe, 2021 saw many initiatives taken by the APAC region to strengthen their capacities for effective preparedness and for the prevention of new and existing infectious diseases.
For Feedback Email Us : communications@biospectrumasia.com
1 North Bridge Road,
#08-08 High Street Centre,
Singapore 179094
Email : communications@biospectrumasia.com
